Celltrion Healthcare Rises 2.1% Amid Uptrend in Biosimilar (Biologic Drug Copy) Theme

On the 21st, the biosimilar (replicated biopharmaceutical) theme showed strength by rising 3.06% compared to the previous day, while Celltrion Healthcare, which is attracting attention as a related stock, surged 2.1% compared to the previous day. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.

[Graph] Major stock price changes in the biosimilar (replicated biopharmaceutical) theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Celltrion Healthcare's quant financial score is 42.54 points, showing higher stability and profitability scores than the average of other biosimilar (replicated biopharmaceutical) related stocks, but its quant financial ranking was only 9th out of 17 stocks. On the other hand, Dong-A ST ranked first in quant financial ranking with higher growth, stability, and profitability scores compared to other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the robo algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, and other factors.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.